Figures & data
Figure 1 Abdominal CT findings. A CT scan showing diffuse hypodense enlargement of the pancreatic head (arrow).
Abbreviation: CT, computed tomography.
![Figure 1 Abdominal CT findings. A CT scan showing diffuse hypodense enlargement of the pancreatic head (arrow).](/cms/asset/fe300bfc-127d-4ee8-a5ba-25207fbb4423/dott_a_121521_f0001_b.jpg)
Figure 2 A gross pathological examination revealed a 3.0 × 4.0 cm multiseptated mass in the pancreatic head (arrow). The cut surface of the tumor was yellowish (arrow).
![Figure 2 A gross pathological examination revealed a 3.0 × 4.0 cm multiseptated mass in the pancreatic head (arrow). The cut surface of the tumor was yellowish (arrow).](/cms/asset/43bbe2fd-67e1-4c4d-8299-1ad7bf2fae2b/dott_a_121521_f0002_c.jpg)
Figure 3 Histopathology showed small tumor cells without cell adhesion or tissue structure proliferation (A), and HE immunochemical staining was positive for B-cell markers CD20 and CD79a (B, C), compatible with the diagnosis of diffuse large B-cell non-Hodgkin lymphoma. HE immunochemical staining confirmed a proliferative index of over 50–60% (D). (A–C ×400; D ×200).
![Figure 3 Histopathology showed small tumor cells without cell adhesion or tissue structure proliferation (A), and HE immunochemical staining was positive for B-cell markers CD20 and CD79a (B, C), compatible with the diagnosis of diffuse large B-cell non-Hodgkin lymphoma. HE immunochemical staining confirmed a proliferative index of over 50–60% (D). (A–C ×400; D ×200).](/cms/asset/65dda33e-84d0-4ee5-9e80-8111bb8a6c7e/dott_a_121521_f0003_c.jpg)
Figure 4 A PET-CT did not detect any signs of disease recurrence after 16 months.
Notes: A and B represent different planes on PET-CT.
![Figure 4 A PET-CT did not detect any signs of disease recurrence after 16 months.Notes: A and B represent different planes on PET-CT.](/cms/asset/ef86b69d-a369-403b-ae87-b4bdea392a98/dott_a_121521_f0004_c.jpg)
Figure 6 Pathological findings. (A) HE shows irregularly-shaped, atypical lymphocyte infiltration (×40). (B) CD20 positive atypical lymphocytic cells (×400). (C) A high Ki-67 proliferation index (80%; ×200).
![Figure 6 Pathological findings. (A) HE shows irregularly-shaped, atypical lymphocyte infiltration (×40). (B) CD20 positive atypical lymphocytic cells (×400). (C) A high Ki-67 proliferation index (80%; ×200).](/cms/asset/5fe2ae91-9dcd-43a9-8110-c7f1d4e654b7/dott_a_121521_f0006_c.jpg)
Figure 7 Lesions were significantly reduced after 2 cycles of CHOP chemotherapy regimen (A, B). After 4 cycles of CHOP chemotherapy regimen (C, D).
![Figure 7 Lesions were significantly reduced after 2 cycles of CHOP chemotherapy regimen (A, B). After 4 cycles of CHOP chemotherapy regimen (C, D).](/cms/asset/e8da772a-716f-4c58-9770-3a93ba444309/dott_a_121521_f0007_b.jpg)
Table 1 Reported cases of primary pancreatic leiomyosarcoma in the English literature of our review